Event Series

BTEP Distinguished Speakers Seminar Series

Event Description

The Research to Accelerate Cures and Equity (RACE) for Children Act of 2017 requires companies developing targeted cancer drugs for adults to evaluate those drugs for applicability to pediatric cancer. The NCI-funded Pediatric Preclinical In Vivo Testing (PIVOT) consortium collaborates with industry partners to perform rigorous preclinical testing of novel targeted agents using in vivo models of common pediatric cancers. As pediatric cancer is rare, assembling sufficient numbers of patients for clinical trials is challenging. It highlights the importance of effective preclinical testing for identifying promising agents and agents with low potential for improving treatment options for children with cancer.

Hosted By

Bioinformatics Training & Education Program (BTEP)

Sponsored By

Center for Cancer Research